-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Nch2OxLQZNbdpc2/xcGBnl1yANm43+KdNXNTk/VXW4v5BTQAaxueM9/vEBHMI+bs XnheixxvsHU0YO0LsAegVA== 0000930413-07-006065.txt : 20070718 0000930413-07-006065.hdr.sgml : 20070718 20070718141249 ACCESSION NUMBER: 0000930413-07-006065 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20070717 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20070718 DATE AS OF CHANGE: 20070718 FILER: COMPANY DATA: COMPANY CONFORMED NAME: VITAL SIGNS INC CENTRAL INDEX KEY: 0000865846 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 112279807 STATE OF INCORPORATION: NJ FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-18793 FILM NUMBER: 07986216 BUSINESS ADDRESS: STREET 1: 20 CAMPUS RD CITY: TOTOWA STATE: NJ ZIP: 07512 BUSINESS PHONE: 2017901330 MAIL ADDRESS: STREET 1: 20 CAMPUS RD CITY: TOTOWA STATE: NJ ZIP: 07512 8-K 1 c49485_8k.htm c49485_8k.htm -- Converted by SEC Publisher, created by BCL Technologies Inc., for SEC Filing

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

     FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported): July 17, 2007


VITAL SIGNS, INC.

(Exact Name of Registrant as Specified in its Charter)

New Jersey  0-18793     11-2279807 
(State or Other Jurisdiction  (Commission File Number)   (IRS Employer 
of Incorporation)    Identification No.) 


20 Campus Road, Totowa, New Jersey    07512 
(Address of principal executive offices)    (Zip Code) 

Registrant’s telephone number, including area code (973) 790-1330

          Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

          [ ]      Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

          [ ]      Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a -12)

          [ ]      Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d -2(b))

          [ ]      Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e -4(c))


Item 8.01   Other Events.

          On July 17, 2007, Vital Signs, Inc. (the “Company”) issued a press release announcing the acquisition of Southern Sleep Technologies, LLC and Southern Home Respiratory Care, LLC. A copy of this press release is being furnished as Exhibit 99.1 to this Current Report on Form 8-K.

 

 

-2-


Item 9.01   Financial Statements and Exhibits.

(c)      Exhibits.

                    Exhibit 99.1: Press release, dated July 17, 2007.

 

-3-


SIGNATURE

          Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

  VITAL SIGNS, INC.
 
 
 
  By: /s/ Jay Sturm 
    Name: Jay Sturm
    Title: Vice President / General Counsel

Dated: July 17, 2007

 

-4-


EXHIBIT INDEX

Exhibit No.                             Description 
     
99.1    Press release, dated July 17, 2007 

 

-5-


EX-99.1 2 c49485_ex99-1.htm c49485_ex99-1.htm -- Converted by SEC Publisher, created by BCL Technologies Inc., for SEC Filing

NEWS RELEASE
FOR IMMEDIATE RELEASE

VITAL SIGNS, INC. COMPLETES SLEEP ACQUISITION

          TOTOWA, N.J., July 17, 2007 -- VITAL SIGNS, INC. (NASDAQ: VITL) today announced acquisitions of a sleep diagnostic company and a durable equipment supplier in its Sleep Segment business unit.

          Sleep Services of America, Inc. (SSA), a majority owned Vital Signs subsidiary, acquired the assets of Southern Sleep Technologies, LLC and Southern Home Respiratory Care LLC. Southern Sleep Technologies, LLC primarily provides sleep diagnostic services in both free standing and hospital owned sleep laboratories, and Southern Home Respiratory Care LLC is a provider of CPAP equipment to sleep apnea patients.

          John Mathias, President of SSA said, “These acquisitions allow SSA to expand its geographic coverage in the greater Atlanta area. This acquisition propels our strategy of providing the patient with a complete range of sleep services. By guiding patients through the diagnostic procedure, through the training and use of CPAP devices and through follow-up services, SSA is uniquely positioned to address the patient’s sleep needs. We are excited that the founder and owner of the business will be staying with us to develop and improve the delivery of sleep diagnostic and therapeutic services.”

          Southern Sleep and Southern Home Respiratory had revenue of $2.1 Million in 2006 and the acquisition costs are approximately $3 million. Vital Signs now owns 73% of SSA, with the Johns Hopkins Health System Corporation owning 26%.

          Vital Signs, Inc. and its subsidiaries design, manufacture and market primarily single-use medical products for the anesthesia, respiratory/critical care, sleep/ventilation and interventional cardiology/radiology markets achieving the number one market share position in five of its major product categories. Vital Signs is ISO 13485 certified and has CE Mark approval for its products. In 2006 Forbes Magazine named Vital Signs, Inc. as “one of the 200 Best Small Companies in the America” based on financial criteria.

          All statements in this press release (including statements regarding future success in the penetration of new markets) other than historical statements constitute Forward-Looking Statements under the Private Securities Litigation Reform Act of 1995. Actual results could differ materially from such statements as a result of a variety of factors, the ability to integrate new subsidiaries, the reaction of competitors and the risk factors referred to by Vital Signs in its Annual Report on Form 10-k for the year ended September 30th, 2006.

VITL-G  
FOR FURTHER INFORMATION, CONTACT:    Terry D. Wall, President
or William Craig, CFO
(973) 790-1330

http://www.vital-signs.com
 

 


-----END PRIVACY-ENHANCED MESSAGE-----